266 related articles for article (PubMed ID: 3296437)
21. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells.
Street SE; Hayakawa Y; Zhan Y; Lew AM; MacGregor D; Jamieson AM; Diefenbach A; Yagita H; Godfrey DI; Smyth MJ
J Exp Med; 2004 Mar; 199(6):879-84. PubMed ID: 15007091
[TBL] [Abstract][Full Text] [Related]
22. [Molecular mechanisms of tumor and immune system interaction].
Berezhnoĭ AE; Gnuchev NV; Georgiev GP; Kozlov AM; Larin SS
Vopr Onkol; 2008; 54(6):669-83. PubMed ID: 19241839
[No Abstract] [Full Text] [Related]
23. Age-related changes of natural antitumor resistance in spontaneously hypertensive rats with T-cell depression.
Matsuoka T; Takeichi N; Kobayashi H
Cancer Res; 1987 Jul; 47(13):3410-3. PubMed ID: 3495330
[TBL] [Abstract][Full Text] [Related]
24. [Recent studies on tumor immunity and prospects for therapy of neoplasms].
Aoki Y; Tanaka K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Aug; 47(8):863-71. PubMed ID: 7594896
[No Abstract] [Full Text] [Related]
25. Multiple roles for CD4+ T cells in anti-tumor immune responses.
Kennedy R; Celis E
Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
[TBL] [Abstract][Full Text] [Related]
26. Use of activated natural killer cells for tumor immunotherapy in mouse and human.
Basse PH; Whiteside TL; Herberman RB
Methods Mol Biol; 2000; 121():81-94. PubMed ID: 10818719
[No Abstract] [Full Text] [Related]
27. Links between innate and cognate tumor immunity.
Ghiringhelli F; Apetoh L; Housseau F; Kroemer G; Zitvogel L
Curr Opin Immunol; 2007 Apr; 19(2):224-31. PubMed ID: 17303400
[TBL] [Abstract][Full Text] [Related]
28. Effector immune mechanisms in cancer.
Lotzová E
Nat Immun Cell Growth Regul; 1985; 4(6):293-304. PubMed ID: 3911064
[No Abstract] [Full Text] [Related]
29. The gene therapy of cancer: transgenic immunotherapy.
Zwiebel JA; Su N; MacPherson A; Davis T; Ojeifo JO
Semin Hematol; 1993 Oct; 30(4 Suppl 4):119-28; discussion 129. PubMed ID: 8303305
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppression mediated by tumor cells: a challenge for immunotherapeutic approaches.
Paillard F
Hum Gene Ther; 2000 Mar; 11(5):657-8. PubMed ID: 10757345
[No Abstract] [Full Text] [Related]
31. [Cellular immune mechanism against cancer cells and immunotherapy of cancer].
Kikuchi K
Nihon Hinyokika Gakkai Zasshi; 1990; 81(13 Suppl):1977. PubMed ID: 2131367
[No Abstract] [Full Text] [Related]
32. Natural immunity. History, present, and future.
Lotzová E
Nat Immun Cell Growth Regul; 1983-1984; 3(1):1-6. PubMed ID: 6379426
[No Abstract] [Full Text] [Related]
33. Induction of immune tolerance: a role for Natural killer T lymphocytes?
Margalit M; Ilan Y
Liver Int; 2005 Jun; 25(3):501-4. PubMed ID: 15910485
[TBL] [Abstract][Full Text] [Related]
34. Immune surveillance and immunotherapy: lessons from carbohydrate mimotopes.
Pashov A; Monzavi-Karbassi B; Kieber-Emmons T
Vaccine; 2009 May; 27(25-26):3405-15. PubMed ID: 19200843
[TBL] [Abstract][Full Text] [Related]
35. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes.
Rosenberg SA; Lotze MT
Annu Rev Immunol; 1986; 4():681-709. PubMed ID: 3518753
[No Abstract] [Full Text] [Related]
36. [Tumor immunology].
Milas L; Silobrcić V
Lijec Vjesn; 1970; 92(1):5-33. PubMed ID: 4932237
[No Abstract] [Full Text] [Related]
37. Cancer immunotherapy: a treatment for the masses.
Blattman JN; Greenberg PD
Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
[TBL] [Abstract][Full Text] [Related]
38. Mistaken notions about natural killer cells.
Yokoyama WM
Nat Immunol; 2008 May; 9(5):481-5. PubMed ID: 18425104
[TBL] [Abstract][Full Text] [Related]
39. [A new approach to immunotherapy of cancer based on autologous T-lymphocytes].
Dosne Pasqualini C; Laguens RP
Medicina (B Aires); 1987; 47(3):307-12. PubMed ID: 3326997
[No Abstract] [Full Text] [Related]
40. [Antitumor immunity].
Gordienko SP
Vopr Onkol; 1987; 33(4):87-91. PubMed ID: 3296436
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
